Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Diamedica Inc V.DMA

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  DMCAF

Diamedica Inc is a development stage biopharmaceutical company. The Company is engaged in the discovery and development of drugs for the treatment of diabetes and related diseases.
Price: $0.29 | Change: $0.00 | %Change: 0.00%
Volume: 53,840 | Day High/Low: 0.31/0.29 | 52 Week High/Low: 1.10/0.28

Snapshot

Last Traded: October 24, 2014 10:54 Transaction Volume: 53,840
Open: $0.29 Previous Close: $0.29
Bid: $0.29 Ask: $0.31
Bid Size: 7,500 Ask Size: 1,500
Market Cap: $18.0m Shares Out: 62.0m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • RE:RE:?

    4.5 stars

    How about the big holders want more cheap stock and will announce the results AFTER the offering. The key is not the results first, but...

    4.5 stars


  • RE:?

    0 stars

    We've known all along that they had no cash. It was my biggest reservation about investing here. I'm hoping the trials results are...

    2 stars


  • ?

    0 stars

    So are they out of cash, as per their previous NR, and they are only able to raise money at 30 cent shares? Or are the next phase trials...

    2.5 stars


  • RE:RE:RE:Starting to get scary....

    0 stars

    Relatively high yes but still not huge volume. I can't even remember the last time this traded over 100K shares in a session. I also...

    2.5 stars


  • RE:RE:Starting to get scary....

    0 stars

    We're just shy of all time low of Diamedica....this right when we expect the results fron the phase 2b trials makes me nervous...

    2 stars